In Conversation

We do logistics differently than our competition in Europe

Our vision is to become an easily adaptable company, bringing novel treatment options to patients living with difficult to treat conditions while continuing to give the…

In 2017 alone, the allocations of EIB funds in Turkey amounted to EUR 1.5 billion and were channelled to more than 3,700 small and medium-sized companies…

It is difficult to define Turkey as either a generic or original product market. Instead, it could be said that Turkey is a heavily branded market

At Selçuk, we have a motto: balance, stability and trust. We have abided by this motto ever since our founding.

Through its Sandoz division, Novartis has been in Turkey since 1930

From my experience in Brazil, I could apply my skills and knowledge in Turkey effectively

In crisis there is opportunity for those who are willing to take it

The discrepancy between the Euro exchange value and the fixed exchange rate for drugs is an ongoing dilemma.

The localization of vaccine production will be a groundbreaking achievement for Turkey.

Our success rate for on time and on site delivery shall never dive under 99 percent

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here